Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1725857

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1725857

Global Atherectomy Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2990
PDF (5 User License + Excel)
USD 3490
PDF (Corporate License)
USD 3990

Add to Cart

Global Atherectomy Devices Market Trends & Summary

Atherectomy Devices Market is expected to reach US$ 2.21 billion 2033 from US$ 1.05 billion in 2024, with a CAGR of 8.63% from 2025 to 2033. Some of the major factors propelling the atherectomy market's growth include the rise in peripheral artery disease (PAD), notable technological advancements, an aging population, the introduction of minimally invasive surgeries, the development of healthcare infrastructure, and reimbursement policies in emerging economies.

Atherectomy Devices Market Global Report by Product Type (Directional, Rotational, Orbital, Laser), Application (Cardiovascular, Neurovascular, Peripheral Vascular), End User (Hospitals, Ambulatory Care Service, Medical Research Institutes), Countries and Company Analysis 2025-2033.

Atherectomy Devices Industry Overview

Medical devices called atherectomy devices are used to remove plaque from arteries, usually in patients who have coronary artery disease (CAD) or peripheral arterial disease (PAD). By manually removing, grinding, or vaporizing the plaque, these devices help to restore blood flow and lessen symptoms like chest or leg pain. Because atherectomy techniques are less intrusive than traditional surgery and need less recovery time, they are frequently chosen. Rotational, directional, laser, and orbital atherectomy systems are among the several types of atherectomy equipment. These tools are essential for enhancing patient outcomes, especially for patients who are not suitable candidates for stent insertion or balloon angioplasty.

The market for atherectomy devices is expanding due to a number of causes, including an aging population, the growing prevalence of cardiovascular illnesses, and growing awareness of less invasive procedures. Improved device designs and efficacy, among other technological developments, have increased the use of these treatments for arterial blockages. Further driving market expansion are advantageous reimbursement policies and expanding access to healthcare in developing nations. The demand for atherectomy devices as a preferred therapeutic option for the management of arterial disease is increased by these variables taken together.

Growth Drivers for the Atherectomy Devices Market

Peripheral Artery Disease (PAD) Cases Are Increasing

The market for atherectomy devices is expanding because to the rise in diabetes, obesity, and PAD patients worldwide brought on by an aging population. Eight to twelve million Americans suffer from PAD, particularly those over fifty. Of these, 6.5 million people over 40 have a PAD diagnosis. As a significant alternative in vascular procedures, atherectomy devices offer a minimally invasive method of removing arterial plaque. The gadget improves blood flow and lessens symptoms like exhaustion and leg pain. These devices assist restore arterial patency by vaporizing or physically cutting away the plaque, which greatly improves patient outcomes for those with severe cases of PAD.

Technological Advancements

The market for atherectomy devices is growing significantly due to technological improvements. Device design advancements have increased their effectiveness in treating artery blockages by increasing their efficiency, accuracy, and safety. For example, improvements in orbital, laser, and rotational atherectomy technologies have improved the ability to remove plaque with the least amount of damage to vessels. By combining real-time imaging techniques like optical coherence tomography (OCT) and intravascular ultrasonography (IVUS), doctors can more easily see and navigate arterial blockages. Further driving the market's expansion are newer, easier-to-use gadgets with superior ergonomic designs that enable speedier treatments and better patient results.

In Aug 2022, AngioDynamics, Inc. announced that the Auryon Atherectomy System has gained 510(k) clearance for an expanded indication that includes arterial thrombectomy.

Expansion into Emerging Markets

For atherectomy devices, entering emerging markets is a major growth driver. Advanced medical technology are becoming more and more in demand as healthcare infrastructure in places like the Middle East, Asia-Pacific, and Latin America improves. Atherectomy devices are becoming more popular as a result of growing knowledge of cardiovascular disorders and more disposable income in these places. Atherectomy procedures are also becoming more popular in these areas due to advantageous government initiatives, better healthcare legislation, and easier access to cutting-edge treatments.

Challenges in the Atherectomy Devices Market

Lack of Skilled Operators

One major issue facing the market for atherectomy devices is the shortage of qualified operators. To guarantee accuracy and reduce problems, these operations call for specific training and experience. High degrees of skill are required due to the difficulty of employing various atherectomy technologies, such as rotating or laser systems. The adoption of these devices may be limited by a lack of qualified personnel, which could result in less than ideal results. Further impeding the widespread adoption of atherectomy devices, particularly in underserved areas, is the time-consuming and expensive nature of the training process.

High Costs

One of the biggest obstacles to the market for atherectomy devices is their high cost, which prevents many people from using them, especially in areas with low and intermediate incomes. Healthcare providers may be discouraged from investing in these devices due to the high production and procurement costs associated with their sophisticated technology. Additionally, patients may find the procedure's cost-which includes hospital costs and gadget usage-to be unaffordable, particularly in places with less advantageous reimbursement policies. Even while atherectomy therapies are successful in controlling cardiovascular problems, access to them may be limited by this price barrier.

Atherectomy Devices Market Overview by Regions

The market for atherectomy devices is growing internationally, with North America leading the way because of its sophisticated healthcare system and strong demand for minimally invasive procedures. Europe comes in second, primarily due to the rise in incidence of cardiovascular disease. The Asia-Pacific region is expanding quickly as a result of increased awareness, better access to healthcare, and economic prosperity. Due to rising healthcare spending and the need for cutting-edge medical technology, markets in Latin America and the Middle East are also expanding.

United States Atherectomy Devices Market

The growing geriatric population in the United States is the main factor driving the growth of the atherectomy devices market. The predicted number of elderly Americans is 55.8 million, or 16.8% of the overall population, based on census data released in May 2023. The need for these devices is growing since atherectomy is a treatment for peripheral artery disease (PAD), which is more common in older people.

Additionally, the market is expanding due to the rise in chronic conditions including PAD and atherosclerosis. High cholesterol, obesity, and diabetes all contribute to atherosclerosis, which results in artery blockages that frequently necessitate atherectomy treatments. About 25 million adults in the United States have excessive cholesterol, which raises the risk of atherosclerosis, according to a May 2024 CDC research. Since atherectomy devices provide a successful, minimally invasive therapy option for restoring blood flow and lowering problems in affected individuals, it is anticipated that the rising prevalence of cardiovascular disorders will continue to drive the demand for these devices.

Germany Atherectomy Devices Market

The growing frequency of cardiovascular disorders, especially peripheral artery disease (PAD), among the elderly population is driving growth in the German market for atherectomy devices. The adoption of atherectomy devices is being driven by Germany's well-established healthcare system as well as growing awareness of minimally invasive therapies. Favorable reimbursement rules and technological developments in device design further support market expansion. Furthermore, the demand for atherectomy treatments is supported by the increased prevalence of risk factors such as diabetes, obesity, and high cholesterol.

India Atherectomy Devices Market

Due to the rising incidence of cardiovascular disorders, especially peripheral artery disease (PAD), among the vast population of India, the market for atherectomy devices is expanding significantly. The need for atherectomy treatments is being driven by an aging population and rising risk factors like obesity, diabetes, and high cholesterol. Market acceptance is also being aided by India's developing healthcare system and rising awareness of minimally invasive procedures. In the upcoming years, the market is anticipated to grow even more due to favorable government regulations, expanding access to healthcare, and technological advancements in atherectomy devices.

Saudi Arabia Atherectomy Devices Market

The market for atherectomy devices is expanding in Saudi Arabia as a result of an aging population and an increase in cardiovascular disorders, particularly peripheral artery disease (PAD). Demand is being driven by improvements in healthcare access, atherectomy technology breakthroughs, and increased awareness of minimally invasive procedures. The healthcare system in Saudi Arabia is also making investments in cutting-edge medical technology, which encourages the use of atherectomy tools for the efficient treatment of arterial blockages.

Atherectomy Devices Market Segments

Product Type

1. Directional

2. Rotational

3. Orbital

4. Laser

Application

1. Cardiovascular

2. Neurovascular

3. Peripheral Vascular

End User

1. Hospitals

2. Ambulatory Care Service

3. Medical Research Institutes

Countries

North America

1. United States

2. Canada

Europe

1. France

2. Germany

3. Italy

4. Spain

5. United Kingdom

6. Belgium

7. Netherlands

8. Turkey

Asia Pacific

1. China

2. Japan

3. India

4. South Korea

5. Thailand

6. Malaysia

7. Indonesia

8. Australia

9. New Zealand

Latin America

1. Brazil

2. Mexico

3. Argentina

Middle East & Africa

1. Saudi Arabia

2. UAE

3. South Africa

Rest of the World

All the Key players have been covered from 5 Viewpoints:

1. Overview

2. Key Persons

3. Product Portfolio

4. Recent Development & Strategies

5. Revenue Analysis

Key Players Analysis

1. Boston Scientific Corporation, Inc.

2. Abbott Laboratories

3. Medtronic plc

4. Cardinal Health

5. Terumo Corporation

6. Integer Holdings Corporation

7. Becton, Dickinson and Company

8. AngioDynamics Inc.

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges
  • 4.3 Opportunities

5. Global Atherectomy Devices Market

6. Market Share Analysis

  • 6.1 By Product Type
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Product Type

  • 7.1 Directional
  • 7.2 Rotational
  • 7.3 Orbital
  • 7.4 Laser

8. Application

  • 8.1 Cardiovascular
  • 8.2 Neurovascular
  • 8.3 Peripheral Vascular

9. End User

  • 9.1 Hospitals
  • 9.2 Ambulatory Care Service
  • 9.3 Medical Research Institutes

10. Countries

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherlands
    • 10.2.8 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Thailand
    • 10.3.6 Malaysia
    • 10.3.7 Indonesia
    • 10.3.8 Australia
    • 10.3.9 New Zealand
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 Saudi Arabia
    • 10.5.2 UAE
    • 10.5.3 South Africa
  • 10.6 Rest of the World

11. Porter's Five Forces Analysis

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Key Players Analysis

  • 13.1 Boston Scientific Corporation, Inc.
    • 13.1.1 Overview
    • 13.1.2 Key Persons
    • 13.1.3 Product Portfolio
    • 13.1.4 Recent Development & Strategies
    • 13.1.5 Revenue Analysis
  • 13.2 Abbott Laboratories
    • 13.2.1 Overview
    • 13.2.2 Key Persons
    • 13.2.3 Product Portfolio
    • 13.2.4 Recent Development & Strategies
    • 13.2.5 Revenue Analysis
  • 13.3 Medtronic plc
    • 13.3.1 Overview
    • 13.3.2 Key Persons
    • 13.3.3 Product Portfolio
    • 13.3.4 Recent Development & Strategies
    • 13.3.5 Revenue Analysis
  • 13.4 Cardinal Health
    • 13.4.1 Overview
    • 13.4.2 Key Persons
    • 13.4.3 Product Portfolio
    • 13.4.4 Recent Development & Strategies
    • 13.4.5 Revenue Analysis
  • 13.5 Terumo Corporation
    • 13.5.1 Overview
    • 13.5.2 Key Persons
    • 13.5.3 Product Portfolio
    • 13.5.4 Recent Development & Strategies
    • 13.5.5 Revenue Analysis
  • 13.6 Integer Holdings Corporation
    • 13.6.1 Overview
    • 13.6.2 Key Persons
    • 13.6.3 Product Portfolio
    • 13.6.4 Recent Development & Strategies
    • 13.6.5 Revenue Analysis
  • 13.7 Becton, Dickinson and Company
    • 13.7.1 Overview
    • 13.7.2 Key Persons
    • 13.7.3 Product Portfolio
    • 13.7.4 Recent Development & Strategies
    • 13.7.5 Revenue Analysis
  • 13.8 AngioDynamics Inc.
    • 13.8.1 Overview
    • 13.8.2 Key Persons
    • 13.8.3 Product Portfolio
    • 13.8.4 Recent Development & Strategies
    • 13.8.5 Revenue Analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!